16/100Is AXTI-AXT, a buy?
Tuesday 20 October 2026
Why now: The current tape includes a 10.3% premarket jump, while the business has a newly disclosed multi-year customer commitment tied to optical-networking demand. The timing case is still weak because the completed daily chart remains far below its intermediate trend and has not confirmed a recovery.
Upside: The consensus price target is $99.50, implying 75.2% upside from the supplied live price. That target depends on AXT converting optical demand and reserved capacity into a much stronger earnings profile.
Risks: The main risks are that export permissions or customer order timing delay shipments, and that the company fails to restore margins despite higher revenue. The valuation leaves little room for another period of losses and cash burn.
Sign up or log in for access
Unlock the full scorecard, detailed analysis, and research notes. Free — no credit card needed.
Scorecard
| Scorecard | 16/100 | |
|---|---|---|
| Company Detail | AXTI - AXT, Inc. | |
| Price as at 19 October 2026 | $56.79 | |
| Market cap | $3.7B | |
| Quality and Fundamental Score (100) | ||
| Breakout / Early-Momentum /20 | 0/20 | |
| Rev/EPS Momentum /20 | 0/20 | |
| Business Quality /15 | 5/15 | |
| Balance Sheet /15 | 3/15 | |
| Valuation /10 | 0/10 | |
| Industry Relative Strength /10 | 0/10 | |
| Macro / Sector Tailwind /10 | 8/10 | |
| Growth | ||
| Cash runway | 21.9 yr | |
| Revenue YoY | -11.1% | |
| EPS YoY | -81.5% | |
| FCF YoY | -5.0% | |
| Gross margin | 12.7% | |
| Valuation & Trend | ||
| Trailing P/E | 2376.2x | |
| Forward P/E | 66.3x | |
| RSI (14d) | 40 | |
| vs 50d SMA | -19.1% | |
| Support cushion | −6.0% | |
| Sentiment | ||
| Wall Street verdict | Mixed | |
| News tone | Quiet | |
| Dividend | — | |
How are these colored?
| Metric | Strong metrics | Solid metrics | Selective | Caution | Unfavourable |
|---|---|---|---|---|---|
| Overall score | ≥ 80 | 70-79 | 60-69 | 50-59 | < 50 |
| Business quality /15 | ≥ 12 | 10-11 | 8-9 | 6-7 | < 6 |
| Balance sheet /15 | ≥ 12 | 10-11 | 8-9 | 6-7 | < 6 |
| Market cap | ≥ $20B | $5B-$20B | $2B-$5B | $1B-$2B | < $1B |
| Cash runway | ≥ 3 yr or cash generative | 1.5-3 yr | 0.75-1.5 yr | 0.25-0.75 yr | < 0.25 yr |
| Revenue YoY | ≥ 15% | 5-15% | 0-5% | -5-0% | < -5% |
| EPS YoY | ≥ 20% | 5-20% | 0-5% | -5-0% | < -5% |
| FCF YoY | ≥ 10% | 1-10% | 0-1% | -5-0% | < -5% |
| Gross margin | ≥ 60% | 40-60% | 25-40% | 10-25% | < 10% |
| Trailing P/E | < 15 | 15-25 | 25-35 | 35-40 | > 40 or neg |
| Forward P/E | < 15 | 15-25 | 25-35 | 35-40 | > 40 or neg |
| RSI (14d) | 50-70 | 45-50 or 70-75 | 40-45 or 75-78 | 30-40 or 78-80 | < 30 or > 80 |
| vs 50d SMA | +2% to +15% | 0-2% or 15-25% | -2-0% or 25-35% | -3--2% or 35-40% | < -3% or > 40% |
| Support cushion | 2-10% above | 0-2% | 10-15% | 15-20% | price below support |
| Wall Street verdict | Aligned | — | Mixed | — | Disagrees |
| News tone | Positive | — | Neutral / Mixed | — | Negative |
| Dividend | Yield ≥ 2% & growing | Growing | Flat payer ≥ 1% | Low / flat | Cutting |
Detailed Analysis — Tuesday 20 October 2026
Morris S.
Gary L.
Receiver of capital expenditure: Yes: AXT receives customer capital spending indirectly because optical-networking, laser, wireless, and data-center equipment makers need compound-semiconductor substrates as they expand device production.
Main customers
- Lumentum Operations, LLC (Verified long-term customer for indium phosphide wafer substrates used in optical and photonic applications.)
- OSRAM (Historically disclosed as a significant customer in prior company commentary; current revenue concentration was not verified.)
Notable contracts
- Lumentum long-term supplier agreement — Runs through December 31, 2031 (AXT agreed to reserve a minimum annual indium phosphide capacity commitment and support incremental capacity needs.)
- AXT has a real strategic role in compound-semiconductor wafers, particularly indium phosphide substrates used in optical links that are becoming more important in artificial intelligence data centers.
- The Lumentum agreement improves demand visibility and supports the view that AXT's technology has value in the supply chain.
- However, the investment case remains dependent on execution: management must turn capacity demand into higher utilization, healthier gross margin, and positive free cash flow.
Scores 16 out of 100. a mixed overall grade. Sector fit scored highest. Business quality and balance sheet weighed on the total. The score is capped by a weak chart, negative free cash flow, low gross margin, share dilution, and an extreme valuation despite the company still reporting an annual net loss. The long-term Lumentum agreement and a strong cash position improve survival and opportunity, but do not yet prove durable profitable growth. Mechanical cap: latest annual net income ≤ 0. Balance Sheet ≤ 3/15, Rev/EPS ≤ 0/20, overall ≤ 50/100.
Component scores are on the scorecard above.
- The completed daily setup is poor: AXTI is below both its 50-day and 200-day moving averages, has suffered large losses over both the past month and past quarter, and has no confirmed breakout.
- Trading activity is also below the prior volume baseline, so the premarket rebound is not yet evidence of durable institutional demand.
- Latest annual revenue was $88.33 million, while net income was negative $21.26 million and free cash flow was negative $18.78 million.
- Gross margin was only 12.7%, a clear sign that the business has not yet recovered sufficient scale or manufacturing absorption.
- The balance sheet is the offset: AXT held $412.17 million in cash, had $473.14 million of working capital, a current ratio of 4.77, and modest total liabilities of $145.34 million.
- Share count has risen 7.09% over five years, so future funding or stock compensation remains a shareholder cost.
Cash runway: 21.9 yr ($412M cash ÷ $19M/yr burn, latest fiscal year).
Upcoming (1–6 months)
- Third-quarter 2026 earnings release and conference call scheduled for October 29, 2026, including any update on shipment levels, export permits, capacity use, and gross margin.
Ongoing
- Track indium phosphide revenue mix, gross-margin recovery, free cash flow, customer concentration, and evidence that Lumentum's reserved capacity turns into recurring shipments.
Risks
- China export-control permits can interrupt indium phosphide shipments and make revenue timing unreliable.
- A small customer base and reliance on a few end markets can produce large swings in orders, utilization, and margin.
- The company's rich valuation could compress sharply if profitability and cash generation do not improve.
Breaks the thesis
- The long-term case is materially weakened if upcoming results show continuing losses and cash burn without a credible path to sustained gross-margin expansion.